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Abstract 
Objective: Currently, it is estimated that one in 10 women of reproductive age are affected by the reproductive 
condition known as endometriosis. However, there has been limited research and policy attention on the prevalence 
of endometriosis in Australia. Utilising a nationally-representative Australian sample (N = 2025), this study aimed to 
report on the prevalence of endometriosis in the general population and to examine the sociodemographic factors 
associated with the condition.
Results: The results identified a prevalence rate for endometriosis of 3.4%, which aligns with previous Australian 
research on this topic. However, the prevalence rate from this data set is lower than the estimate prevalence from the 
Global Burden of Disease Study. In addition, this study reported that women self-reporting diagnosis of endometrio-
sis, were between 40–49 years of age, with a higher proportion living in South Australia (18.2%) compared to women 
within the general population (8.4%). The findings highlight endometriosis as a significant health care issue warrant-
ing further research and policy attention. While acknowledging some limitations, the study provides an important 
foundation for further large-scale research to be conducted on this important women’s health topic.
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Introduction
Endometriosis, defined as the presence of tissue similar 
to endometrial lining growing outside the uterus, has 
recently received research attention with the investiga-
tion of new theories on the pathogenesis of the condi-
tion. These theories hypothesise that the multi-factorial 
disease involves interactions between epigenetics, genet-
ics, immunology, hormonal and inflammatory aspects 
[1]. The disease is heterogeneous, and can cause women 
to experience a variety of debilitating symptomology, 
that negatively impacts their quality of life proportional 
to the severity of their symptoms [2, 3]. Such sympto-
mology includes: dysmenorrhea; menorrhagia; pelvic 
pain; dyspareunia; and infertility; however, women can 
also be asymptomatic. Whilst research examining the 
implications of endometriosis has increased in recent 
years, a robust prevalence figure for this condition in 
Australia has yet to be determined. Research conducted 
in 1997 [4] estimated that globally one in 10 women are 
affected by endometriosis, with more recent research 
proposing up to 30% in women with infertility [5]. How-
ever, these figures are based on studies involving women 
undergoing laparoscopic surgery, representing a sam-
pling bias that is non-representative of the general popu-
lation. While laparoscopic surgery is the gold-standard 
for diagnosis, it is costly and invasive, consequently, 
endometriosis is commonly under diagnosed [6]. Based 
on these figures the World Bank in 2010 estimated that 
176 million women of reproductive age worldwide are 
affected with endometriosis [7]. Australian longitudinal 
data indicates a prevalence rate of endometriosis of 3.7% 
within the age range of 34–39 years [8], with other esti-
mates suggesting 560,000 women in Australia are affected 
[9, 10]. Whilst these figures are estimates, global data has 
shown a 6.4% increase in the prevalence of endometriosis 
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between the years 1998 to 2013 [11]. However, given the 
difficulties in diagnosis, these figures may be inadequate 
and outdated.
During 2016, the Global Consortium of Investigators 
in Endometriosis (GCIE) published an update to the 
global research priorities for endometriosis [12]. Many 
of the GCIE priorities are of significant value to women 
with endometriosis. Nevertheless, without prevalence 
data and an understanding of the costs associated with 
care (including both out-of-pocket expenses and the 
burden on the health care system) it is difficult to justify 
policy change and research funding targeting endome-
triosis. Within the GCIE priorities, it is recommended 
that endometriosis organisations are established to raise 
public and policy-maker awareness [13]. In Australia, 
this movement has been establishment with endome-
triosis not-for-profit organisations including Endome-
triosis Australia [14] and EndoActive [15] as well as the 
Australian Coalition for Endometriosis, a peak national 
advocacy body representing women with endometriosis 
[16]. Movement to lobby the government has only just 
begun, and further research is needed to help alert pol-
icy-makers to this significant topic, for which prevalence 
data would be highly valued [17]. Whilst the above preva-
lence figures may be accepted globally, currently there is 
limited prevalence data on endometriosis in the Austral-
ian population. In direct response, this article reports the 
prevalence of endometriosis in Australian women from 




The study employed a cross-sectional survey design uti-
lising a purposive convenience sample of Australian 
adults aged over 18  years (N = 2025) who were repre-
sentative of the general population with regards to age, 
gender and state/territory of residence [18]. Participants 
were recruited through a database from their mem-
bership with Qualtrics (marketing research company). 
Recruitment occurred between 26 July and 28 August 
2017. Participation in the study required participants to 
provide informed consent prior to beginning the online 
survey. Participants, who completed the survey, received 
a small financial incentive for their time. The incentive is 
based on their membership with Qualtrics. Survey invi-
tations were emailed to Qualtrics members who met the 
inclusion criteria of being 18  years or older. The survey 
consisted of 50 items covering demographics, health 
service utilisation (including complementary medicine), 
health status, health literacy, and health communication. 
Based on pilot testing, the survey completion time was 
approximately 15 min. The study analysed demographic 
data gathered from women with endometriosis as part of 
the larger survey. Women were included in the analysis 
if they selected endometriosis for the survey item ‘In the 
last 3 years, have you been diagnosed or treated for?’. This 
study has been reported in adherence to the STROBE 
Statement. Using STATA 14, a chi-squared test was used 
to calculate descriptive statistics and compare the char-
acteristics of women with endometriosis to women in 
the general population. Cramer’s V was used to test the 
strength of association. A Fisher’s exact test was used to 
compare categorical variables. Statistical significance was 
set to p < 0.05.
Results
There were 2025 respondents to the survey of which six 
responses were classified as incomplete or unreliable data 
and were removed from the data set, leaving 2019 partici-
pants. From the 2019 participants included in the survey, 
652 were identified as being women of reproductive age 
(between 18 and 49 years). Twenty-two of these women 
(3.4%) reporting being diagnosed with endometriosis 
over the last 3 years. There was no statistically significant 
association between sociodemographic characteristics 
and women in the general population or those with endo-
metriosis except for financial management (p = 0.021), 
however, this had a weak association (Cramer’s V = 0.13). 
Women self-reporting diagnosis of endometriosis were 
more likely to be within 40–49 years of age, with a higher 
proportion of women living in South Australia (18.2%) 
compared to women within the general population 
(8.4%). There was no statistically significant difference 
between women with endometriosis and women in the 
general population in marital status, employment, level 
of education, having a health care card, or private health 
insurance. The results are displayed in Table 1.
Discussion
This is the first study that describes the prevalence of 
self-reported diagnosed endometriosis utilising a nation-
ally representative sample in Australia. This data suggests 
that 3.4% of reproductive-aged Australian women are 
diagnosed with endometriosis. Based on extrapolation 
of the findings, this represents approximately 276,144 
women in Australia [19]. This data also suggests that 
endometriosis affects women indiscriminately and with 
no socio-demographic factors influencing prevalence. 
Our data also represents a significantly lower number 
than previous estimates of 560,000 Australian women 
affected with endometriosis [9, 10]. The results of this 
study align with a recent study using the Australian Lon-
gitudinal Study on Women’s Health survey in a sample 
of 7427 women between 34 and 39  years of age, with a 
reported prevalence of 3.7% for endometriosis [8], and 
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also align with the estimated prevalence of 4.8% between 
the years 2006 to 2013 by the Global Burden of Disease 
Study [11].
The prevalence reported in our study being lower 
than previous estimations, may be due to undiagnosed 
endometriosis and lack of policy-maker awareness 
which is now present with the development of the 
National Endometriosis Plan [20] and the Australian 
Coalition for Endometriosis [16]. The prevalence of 
endometriosis is commonly undiagnosed due to a vari-
ety of reasons including: the normalisation of abnormal 
Table 1 Sociodemographic characteristics of survey participants compared with women diagnosed with endometriosis
*Cramer’s V test measure of association defined as: negligible association (0.00–0.10); weak association (0.10–0.20); moderate association (0.20–0.40); relatively strong 
association (0.40–0.60); strong association (0.60–0.80); very strong association (0.80–1.00)





n % n %
Age (years)
 18–29 247 39.2 6 27.3 0.47 0.04
 30–39 164 26.1 6 27.3
 40–49 219 34.8 10 45.4
State
 Australian capital territory 10 1.6 0 0.0 0.61 0.07
 New South Wales 191 30.3 7 31.8
 Northern territory 1 0.2 0 0.0
 Queensland 151 24.0 3 13.6
 South Australia 53 8.4 4 18.2
 Tasmania 17 2.7 1 4.5
 Victoria 141 22.4 5 22.7
 Western Australia 66 10.5 2 9.1
Marital status
 Never married 221 35.1 9 40.9 0.52 0.07
 Married 223 35.4 8 36.4
 De facto (opposite sex) 101 16.0 1 4.5
 Defector (same sex) 12 1.9 0 0.0
 Separate/divorced/widowed 73 11.6 4 18.2
Highest qualification
 Less than year 12 66 10.5 0 0.0 0.35 0.07
 Year 12 or equivalent 150 23.8 4 18.2
 Trade/apprenticeship 199 31.6 9 40.9
 University degree 215 34.1 9 40.9
Employment status
 Full time 187 29.7 6 27.3 0.20 0.10
 Part time 163 25.9 3 13.6
 Casual/temp 69 10.9 6 27.3
 Looking for work 88 14.0 2 9.1
 Not in paid work 123 19.5 5 22.7
Financial management
 It is impossible/difficult all of the time 147 23.3 7 31.8 0.02 0.13
 It is difficult some of the time 265 42.1 5 22.7
 It is not too bad 191 30.3 6 27.3
 It is easy 27 4.3 4 18.2
Health care
 Health care card 287 45.6 12 54.5 0.26 0.03
 Private health insurance 337 53.5 9 40.9 0.17 0.04
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menstruation by women and medical professionals 
[21]; lack of awareness and education of medical pro-
fessionals; social concealment of menstruation [22]; 
and delay in diagnosis [23, 24]. These issues have been 
explored elsewhere and highlight women’s reports of 
being dismissed by medical professionals and unable 
to gain access for further investigation or referrals [21, 
22, 25]. Without a clear understanding of endometrio-
sis, the delay in diagnosis will continue to be hindered 
until women and medical professionals can clearly 
distinguish the condition and understand that the 
symptoms being experienced are not normal presen-
tations of menstruation [26]. This is important for not 
only understanding the disease and clearly identifying 
prevalence rates, but also to acknowledge and appro-
priately support women suffering from this debilitat-
ing condition that has significant negative impacts 
on mental health and wellbeing, personal relation-
ships, social wellbeing, sexual and physical health [3]. 
In addition, the asymptomatic nature of endometrio-
sis that can occur equally impacts on diagnosis, and 
whilst the prevalence of asymptomatic endometriosis is 
not currently known, one study identified an increase 
in endometriosis diagnosis from women undergoing 
laparoscopic sterilisation [27]. Currently, laparoscopic 
investigation is regarded as the gold standard for diag-
nosis of endometriosis, with non-invasive diagnostic 
methods having insufficient evidence of sensitivity or 
specificity [10], and the invasive and resource-inten-
sive nature of this diagnostic tool is likely to mean that 
many women with endometriosis will remain undi-
agnosed. Consequently, given that our results suggest 
that only half the population estimates for endome-
triosis in Australia have a formal diagnosis, additional 
research attention to non-invasive diagnostic methods 
for endometriosis is warranted. The over-representa-
tion of women with endometriosis in South Australia 
also deserves further examination of factors underlying 
this regional difference may offer important insights to 
clinicians and policy-makers. With the estimation that 
the prevalence of endometriosis is increasing as per 
the Global Burden of Disease Study [11], comes the 
increase in economic burden on the health care system. 
The economic burden of care for women with endome-
triosis was reported to cost $7.7 billion in Australia in 
2014 [9]. In addition, women with endometriosis are 
reported to have a higher risk of several chronic dis-
eases including cancers, autoimmune disease and car-
diovascular disease and in Australia these diseases, are 
a remarkable economic burden to the health care sys-
tem [28] and are identified as National Health prior-
ity areas [29]. In light of the findings of this study and 
given the estimated cost associated with endometriosis 
care, more detailed economic analyses are warranted.
Conclusion
This study further highlights endometriosis as a signifi-
cant health issue among Australian women and identifies 
an estimated prevalence of endometriosis that aligns with 
Australian longitudinal data and the 2013 Global Burden 
of Disease Study. Future research should focus on the 
challenges associated with the diagnosis of endometrio-
sis including the development of a more efficient method 
for diagnosis and the relevant social implications. Due to 
the limitations in this study, further research is needed 
to clearly identify the prevalence of endometriosis in the 
Australian setting utilising a larger nationally representa-
tive sample including women from a larger age-bracket.
Limitations
To the authors’ knowledge this is the first study to 
attempt to identify the prevalence of endometriosis in a 
nationally representative sample. However, the findings 
of this study are not without limitations. First, despite 
being a nationally representative sample, only a small 
section of this sample self-reported being diagnosed with 
endometriosis. Due to this, there may be under report-
ing of the prevalence of endometriosis in Australia from 
this analysis. The analysis also did not include women 
< 18 years and women 50 years of more. Whilst endome-
triosis is considered to affect women of reproductive age, 
the condition may still be present in women of any age. 
In addition, the impact of the small sample size was mini-
mised by using Fishers exact test to examine correlations. 
Acknowledgment of the limitation of the sample recruit-
ment strategy is also warranted. While the sample was 
drawn from participants receiving an incentive, incen-
tives can increase the number of participants completing 
the survey, however this technique can cause selection 
bias, and both increase and decrease non-response bias 
[30, 31]. While this may have resulted in selection bias in 
the reported survey, using incentives in survey research 
is becoming common practise and can increase response 
rates and retention of participants [32]. The survey ques-
tion regarding the 3 year timeframe of receiving a diag-
nosis of endometriosis is also a limitation as it excludes 
women diagnosed or being treated for endometriosis 
outside of this timeframe. Diagnosis of endometriosis 
in this survey is self-reported and does not distinguish 
between visual inspections via laparoscopic investigation 
with positive histology, the gold standard for endometri-
osis diagnosis [33].Consequently, this provided additional 
limitations regarding the objective nature of self-report-
ing and recall. Despite these limitations, this study rep-
resents a first national study investigating self-reported 
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diagnosed endometriosis in Australia. Given the com-
plexity of endometriosis, further research is needed with 
a larger sample of women with diagnosed endometriosis 
to clearly articulate the prevalence of endometriosis in 
the Australian community.
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